Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
0.5587
-0.0703 (-11.18%)
Jul 20, 2026, 11:29 AM EDT - Market open
Evogene Market Cap
Evogene has a market cap or net worth of $5.91 million as of July 20, 2026. Its market cap has decreased by -46.79% in one year.
Market Cap
5.91M
Enterprise Value
5.40M
1-Year Change
-46.79%
Ranking
Category
Stock Price
$0.56
ChartMarket Cap Chart
Since October 15, 2007, Evogene's market cap has decreased from $28.02M to $5.91M, a decrease of -78.90%. That is a compound annual growth rate of -7.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 5.91M | -28.08% |
| Dec 31, 2025 | 8.22M | -36.78% |
| Dec 31, 2024 | 13.00M | -69.10% |
| Dec 31, 2023 | 42.08M | 60.85% |
| Dec 29, 2022 | 26.16M | -63.27% |
| Dec 30, 2021 | 71.23M | -58.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CollPlant Biotechnologies | 6.33M |
| Cadrenal Therapeutics | 6.20M |
| Purple Biotech | 6.18M |
| Pulmatrix | 6.17M |
| Adial Pharmaceuticals | 6.00M |
| Addex Therapeutics | 5.92M |
| Aptevo Therapeutics | 5.91M |
| Curanex Pharmaceuticals | 5.83M |